menu
    • menu

    Company profile for Specifica

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Antibody Libraries are the sources from which therapeutic antibodies can be generated using phage or yeast display. Specifica’s Generation 3 platform generates drug like antibodies, with broad diversity, high affinities and few biophysical liabilities, directly from naïve libraries. In addition to in-house designs, Specifica also collaborates closely with partners to create custom libraries in which essential elements are o...
    Antibody Libraries are the sources from which therapeutic antibodies can be generated using phage or yeast display. Specifica’s Generation 3 platform generates drug like antibodies, with broad diversity, high affinities and few biophysical liabilities, directly from naïve libraries. In addition to in-house designs, Specifica also collaborates closely with partners to create custom libraries in which essential elements are optimized according to partner needs.At Specifica we specialize in the creation of exceptional Antibody Libraries, using cutting edge next generation sequencing (NGS).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SpecificaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    The Santa Fe Railyard 1607 Alcaldesa Street Santa Fe NM 87501
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.specifica.bio/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/specifica-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Velocity Partners With Verified Trials To Prevent Double Enrollment
    Velocity Partners With Verified Trials To Prevent Double Enrollment

    30 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/30/3017902/0/en/Velocity-Clinical-Research-Partners-with-Verified-Clinical-Trials-to-combat-double-enrollment-problem-in-clinical-trials.html

    GLOBENEWSWIRE
    30 Jan 2025
    Share Share
    AIIMS Delhi Hosts Workshop on Emerging Healthcare Technologies
    AIIMS Delhi Hosts Workshop on Emerging Healthcare Technologies

    28 Oct 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/aiims-delhi-hosts-workshop-on-emerging-technologies-for-healthcare-16368

    INDPHARMAPOST
    28 Oct 2024
    Share Share
    OKYO Pharma Doses First Patient in Neuropathic Pain Trial
    OKYO Pharma Doses First Patient in Neuropathic Pain Trial

    23 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/23/2967620/0/en/OKYO-Pharma-Announces-First-Patient-Dosed-in-the-First-Clinical-Trial-to-Treat-Neuropathic-Corneal-Pain.html

    GLOBENEWSWIRE
    23 Oct 2024
    Share Share
    Bioz Revolutionizes Digital Marketing For Product Suppliers
    Bioz Revolutionizes Digital Marketing For Product Suppliers

    08 Oct 2024

    // ACCESSWIRE

    https://www.accesswire.com/927608/bioz-is-driving-the-shift-to-digital-marketing-revolutionizing-the-way-product-suppliers-and-distributors-connect-with-researchers

    ACCESSWIRE
    08 Oct 2024
    Share Share
    Specifica Announces Agreement with Servier and its Subsidiary Symphogen
    Specifica Announces Agreement with Servier and its Subsidiary Symphogen

    29 Mar 2023

    // PRESS RELEASE

    https://servier.com/en/newsroom/specifica-antibody-discovery-platform-transfer-agreement-servier-symphogen/

    PRESS RELEASE
    29 Mar 2023
    Share Share
    Specifica Announces Antibody Discovery Platform Transfer Agreement with Sanofi
    Specifica Announces Antibody Discovery Platform Transfer Agreement with Sanofi

    02 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220602005134/en

    BUSINESSWIRE
    02 Jun 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search